American Century Companies Inc. Trims Holdings in Encompass Health Corporation $EHC

American Century Companies Inc. decreased its position in shares of Encompass Health Corporation (NYSE:EHC) by 10.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 718,138 shares of the company’s stock after selling 81,304 shares during the period. American Century Companies Inc. owned 0.71% of Encompass Health worth $91,218,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Brand Asset Management Group Inc. bought a new stake in shares of Encompass Health during the 3rd quarter valued at $242,000. R Squared Ltd boosted its holdings in Encompass Health by 75.3% in the 3rd quarter. R Squared Ltd now owns 9,286 shares of the company’s stock worth $1,180,000 after buying an additional 3,990 shares during the period. Integrated Advisors Network LLC purchased a new stake in Encompass Health in the 3rd quarter worth $203,000. Intech Investment Management LLC raised its holdings in Encompass Health by 15.7% during the third quarter. Intech Investment Management LLC now owns 21,832 shares of the company’s stock valued at $2,773,000 after acquiring an additional 2,966 shares during the period. Finally, Waddell & Associates LLC purchased a new position in shares of Encompass Health in the third quarter valued at about $305,000. 97.25% of the stock is currently owned by institutional investors.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 150,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer directly owned 377,070 shares of the company’s stock, valued at $42,096,094.80. This trade represents a 28.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on EHC. Barclays increased their target price on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a research report on Friday, February 6th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Finally, Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $143.29.

Encompass Health Trading Down 0.1%

Shares of EHC opened at $107.94 on Wednesday. The stock has a market capitalization of $10.73 billion, a PE ratio of 19.48, a P/E/G ratio of 2.07 and a beta of 0.71. The company’s fifty day moving average is $103.89 and its 200 day moving average is $113.88. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. Encompass Health Corporation has a fifty-two week low of $92.53 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The business had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The business’s revenue was up 9.9% on a year-over-year basis. During the same period last year, the company posted $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, April 1st. Encompass Health’s payout ratio is presently 13.72%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.